Professional Bio
Mohamed Shanshal, MD, is Assistant Professor of Medicine in the Division of Hematology and Oncology within the Department of Medicine and Clinical Director of Thoracic Oncology at Vanderbilt-Ingram Cancer Center (VICC). He joined Vanderbilt University Medical Center in 2026 from Mayo Clinic, where he served as Assistant Professor of Oncology on the clinical educator track.
Dr. Shanshal specializes in thoracic malignancies and early-phase drug development. At Mayo, he contributed to clinical trials, including first-in-human studies, and led translational research in nano-oncology. His work also incorporates novel therapeutics, cellular therapy, and microfluidic tumor models to study targeted drug delivery and optimize cancer treatment strategies.
As Clinical Director, Dr. Shanshal will guide the growth of thoracic oncology at VICC, expanding access to early-phase trials and fostering multidisciplinary collaborations in lung cancer, thymoma, mesothelioma, and other thoracic cancers.
Dr. Shanshal completed his oncology fellowship in 2017, practiced in rural Kentucky, and pursued additional training in thoracic oncology and drug development at Mayo Clinic. His long-term goal is to advance innovative therapeutics through early-phase trials while mentoring the next generation of oncology investigators.
Relevant Links
Education
Residency - Rosalind Franklin University of Medicine and Science, 2014
Fellowship - Texas Tech University, 2017
Fellowship - Mayo Clinic, 2023
Contact
Email
Kimryn.Rathmell@Vumc.Org
Address
777 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232-6307